These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7204198)

  • 1. Fibrinolytic activity without fibrinogenolysis during long-distance racing in horses.
    Ferguson EW; Bernier LL; Shaughness GP; Boucher JH
    J Appl Physiol Respir Environ Exerc Physiol; 1981 Feb; 50(2):245-9. PubMed ID: 7204198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogenolysis and fibrinolysis with strenuous exercise.
    Ferguson EW; Barr CF; Bernier LL
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Dec; 47(6):1157-61. PubMed ID: 536284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the A alpha-chain of fibrinogen and the alpha-polymer of fibrin by the venom of spitting cobra (Naja nigricollis).
    Evans HJ
    Biochim Biophys Acta; 1981 Aug; 660(2):219-26. PubMed ID: 6793073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
    Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
    J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
    Gerner C; Steinkellner W; Holzmann K; Gsur A; Grimm R; Ensinger C; Obrist P; Sauermann G
    Thromb Haemost; 2001 Mar; 85(3):494-501. PubMed ID: 11307821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease.
    Wintroub BU; Coblyn JS; Kaempfer CE; Austen KF
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5448-52. PubMed ID: 7001479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.
    Keber D; Stegnar M; Keber I; Accetto B
    Thromb Haemost; 1979 Jun; 41(4):745-55. PubMed ID: 483247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of breast cancer and mastectomy on fibrinolytic activity in African women.
    Famodu ES; Fakoya AA; Barhua TA; Osime CO; Egwaikhide E; Egbagbe EE; Olu-Edo AN; Osime EO
    Afr J Reprod Health; 2006 Dec; 10(3):114-9. PubMed ID: 17518138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
    Bärtsch P; Haeberli A; Straub PW
    Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.